About pulmonx corp - LUNG
Pulmonx Corp. is a medical technology company, which engages in the provision of interventional pulmonology, planning tools and treatments for obstructive lung diseases. It operates through the following geographical segments: United States, Europe, Middle East, Africa, Asia Pacific, and Other International. The company was founded by Rodney Perkins on December 26, 1995 and is headquartered in Redwood City, CA.
LUNG At a Glance
Pulmonx Corp.
700 Chesapeake Drive
Redwood City, California 94063
| Phone | 1-650-364-0400 | Revenue | 90.50M | |
| Industry | Medical Specialties | Net Income | -54,003,000.00 | |
| Sector | Health Technology | 2025 Sales Growth | 8.006% | |
| Fiscal Year-end | 12 / 2026 | Employees | 296 | |
| View SEC Filings |
LUNG Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | 0.994 |
| Price to Book Ratio | 1.702 |
| Price to Cash Flow Ratio | N/A |
| Enterprise Value to EBITDA | -1.453 |
| Enterprise Value to Sales | 0.843 |
| Total Debt to Enterprise Value | 0.739 |
LUNG Efficiency
| Revenue/Employee | 305,733.108 |
| Income Per Employee | -182,442.568 |
| Receivables Turnover | 7.147 |
| Total Asset Turnover | 0.60 |
LUNG Liquidity
| Current Ratio | 5.06 |
| Quick Ratio | 4.27 |
| Cash Ratio | 3.49 |
LUNG Profitability
| Gross Margin | 74.079 |
| Operating Margin | -59.298 |
| Pretax Margin | -58.982 |
| Net Margin | -59.674 |
| Return on Assets | -35.804 |
| Return on Equity | -77.188 |
| Return on Total Capital | -48.88 |
| Return on Invested Capital | -43.641 |
LUNG Capital Structure
| Total Debt to Total Equity | 104.154 |
| Total Debt to Total Capital | 51.017 |
| Total Debt to Total Assets | 42.077 |
| Long-Term Debt to Equity | 101.722 |
| Long-Term Debt to Total Capital | 49.826 |